Basic Information
| RNALocate ID: | RLID:11002545 |
| RNA Symbol: | hsa-miR-381-3p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-381-3p |
| RNA ID: | miRBase:MIMAT0000736 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11002543 | Exosome | Serum | 18589210 |
| RLID:11002544 | Exosome | Brain tissue | 23382797 |
| RLID:11002546 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
| RLID:11002547 | Microvesicle | Cerebrospinal fluid | 24797360 |
| RLID-D:11000125 | Exosome | Blood|Endothelial cells | |
| RLID-D:11000424 | Microvesicle | Blood|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-381-3p | Oral squamous cell carcinoma | MNDR-E-MI-47037 |
| MNDR | hsa-miR-381-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-47038 |
| MNDR | hsa-miR-381-3p | Ovarian clear cell carcinoma | MNDR-E-MI-47039 |
| MNDR | hsa-miR-381-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-47040 |
| MNDR | hsa-miR-381-3p | Autism spectrum disorder | MNDR-E-MI-47041 |
| MNDR | hsa-miR-381-3p | Lymphoma | MNDR-E-MI-47042 |
| MNDR | hsa-miR-381-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-47043 |
| MNDR | hsa-miR-381-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-47044 |
| MNDR | hsa-miR-381-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-47045 |
| MNDR | hsa-miR-381-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-47046 |
| MNDR | hsa-miR-381-3p | Her2-receptor positive breast cancer | MNDR-E-MI-47047 |
| MNDR | hsa-miR-381-3p | Breast cancer luminal | MNDR-E-MI-47048 |
| MNDR | hsa-miR-381-3p | Lupus nephritis | MNDR-E-MI-47049 |
| MNDR | hsa-miR-381-3p | Dermatomyositis | MNDR-E-MI-47050 |
| MNDR | hsa-miR-381-3p | Prostate cancer | MNDR-E-MI-47051 |
| MNDR | hsa-miR-381-3p | Gastric cancer | MNDR-E-MI-47052 |
| MNDR | hsa-miR-381-3p | Alzheimer disease | MNDR-E-MI-47053 |
| MNDR | hsa-miR-381-3p | Bladder cancer | MNDR-E-MI-47054 |
| MNDR | hsa-miR-381-3p | Esophageal carcinoma | MNDR-E-MI-47055 |
| MNDR | hsa-miR-381-3p | Dysautonomia familial | MNDR-E-MI-47056 |
| MNDR | hsa-miR-381-3p | Myotonic dystrophy | MNDR-E-MI-47057 |
| MNDR | hsa-miR-381-3p | Muscular dystrophy duchenne | MNDR-E-MI-47058 |
| MNDR | hsa-miR-381-3p | Huntington disease | MNDR-E-MI-47059 |
| MNDR | hsa-miR-381-3p | Cardiovascular disease | MNDR-E-MI-47060 |
| MNDR | hsa-miR-381-3p | Lung cancer | MNDR-E-MI-47061 |
| MNDR | hsa-miR-381-3p | Fragile x syndrome | MNDR-E-MI-47062 |
| MNDR | hsa-miR-381-3p | Parkinson disease | MNDR-E-MI-47063 |
| MNDR | hsa-miR-381-3p | Major depressive disorder | MNDR-E-MI-47064 |
| MNDR | hsa-miR-381-3p | Basal-like breast cancer | MNDR-E-MI-47065 |
| MNDR | hsa-miR-381-3p | Thyroid cancer | MNDR-E-MI-47066 |
| MNDR | hsa-miR-381-3p | Pituitary neoplasms | MNDR-E-MI-47067 |
| MNDR | hsa-miR-381-3p | Pancreatic cancer | MNDR-E-MI-47068 |
| MNDR | hsa-miR-381-3p | Melanoma | MNDR-E-MI-47069 |
| MNDR | hsa-miR-381-3p | Rectum adenocarcinoma | MNDR-E-MI-47070 |
| MNDR | hsa-miR-381-3p | Nephroblastoma | MNDR-E-MI-47071 |
| MNDR | hsa-miR-381-3p | Colon cancer | MNDR-E-MI-47072 |
| MNDR | hsa-miR-381-3p | Familial ovarian cancer | MNDR-E-MI-47073 |
| MNDR | hsa-miR-381-3p | Acromegaly | MNDR-E-MI-47074 |
| MNDR | hsa-miR-381-3p | Prostate adenocarcinoma | MNDR-E-MI-47075 |
| MNDR | hsa-miR-381-3p | Pulmonary tuberculosis | MNDR-E-MI-47076 |
| MNDR | hsa-miR-381-3p | Carcinoma ductal breast | MNDR-E-MI-47077 |
| MNDR | hsa-miR-381-3p | Glioblastoma | MNDR-E-MI-47078 |
| MNDR | hsa-miR-381-3p | Glioma | MNDR-E-MI-47079 |
| MNDR | hsa-miR-381-3p | Nemaline myopathy | MNDR-E-MI-47080 |
| MNDR | hsa-miR-381-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-47081 |
| MNDR | hsa-miR-381-3p | Osteosarcoma | MNDR-E-MI-47082 |
| MNDR | hsa-miR-381-3p | Liposarcoma | MNDR-E-MI-47083 |
| MNDR | hsa-miR-381-3p | Inclusion body myositis | MNDR-E-MI-47084 |
| MNDR | hsa-miR-381-3p | Breast carcinoma | MNDR-E-MI-47085 |
| MNDR | hsa-miR-381-3p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-47086 |
| MNDR | hsa-miR-381-3p | Uterine cancer | MNDR-E-MI-47087 |
| MNDR | hsa-miR-381-3p | Gastric adenocarcinoma | MNDR-E-MI-47088 |
| MNDR | hsa-miR-381-3p | Cervical squamous cell carcinoma | MNDR-E-MI-47089 |
| MNDR | hsa-miR-381-3p | Bone-invasive pituitary adenoma | MNDR-E-MI-47090 |
| MNDR | hsa-miR-381-3p | Lung squamous cell carcinoma | MNDR-E-MI-47091 |
| MNDR | hsa-miR-381-3p | Non-small cell lung adenocarcinoma | MNDR-E-MI-47092 |
| MNDR | hsa-miR-381-3p | Lung adenocarcinoma | MNDR-E-MI-47093 |
| MNDR | hsa-miR-381-3p | Adrenocortical carcinoma | MNDR-E-MI-47094 |
| MNDR | hsa-miR-381-3p | Thyroid carcinoma | MNDR-E-MI-47095 |
| MNDR | hsa-miR-381-3p | Papillary thyroid carcinoma | MNDR-E-MI-47096 |
| MNDR | hsa-miR-381-3p | Ovarian carcinoma | MNDR-E-MI-47097 |
| MNDR | hsa-miR-381-3p | Bladder urothelial carcinoma | MNDR-E-MI-47098 |
| MNDR | hsa-miR-381-3p | Carcinoma renal cell | MNDR-E-MI-47099 |
| MNDR | hsa-miR-381-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-47100 |
| MNDR | hsa-miR-381-3p | Renal clear cell carcinoma | MNDR-E-MI-47101 |
| MNDR | hsa-miR-381-3p | Cholangiocarcinoma | MNDR-E-MI-47102 |
| MNDR | hsa-miR-381-3p | Esophageal cancer | MNDR-E-MI-47103 |
| MNDR | hsa-miR-381-3p | Lung small cell carcinoma | MNDR-E-MI-47104 |
| MNDR | hsa-miR-381-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-47105 |
| MNDR | hsa-miR-381-3p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-47106 |
| MNDR | hsa-miR-381-3p | Breast invasive carcinoma | MNDR-E-MI-47107 |
| MNDR | hsa-miR-381-3p | Hepatocellular carcinoma | MNDR-E-MI-47108 |
| MNDR | hsa-miR-381-3p | Familiar ovarian carcinoma | MNDR-E-MI-47109 |
| MNDR | hsa-miR-381-3p | Rheumatoid arthritis | MNDR-E-MI-47110 |
| MNDR | hsa-miR-381-3p | Barrett's adenocarcinoma | MNDR-E-MI-47111 |
| MNDR | hsa-miR-381-3p | Chronic fatigue syndrome | MNDR-E-MI-47112 |
| MNDR | hsa-miR-381-3p | Tonsil cancer | MNDR-E-MI-47113 |
| MNDR | hsa-miR-381-3p | Psoriasis | MNDR-E-MI-47114 |
| MNDR | hsa-miR-381-3p | Colorectal cancer | MNDR-E-MI-47115 |
| MNDR | hsa-miR-381-3p | Stroke lacunar | MNDR-E-MI-47116 |
| MNDR | hsa-miR-381-3p | Barrett's carcinogenesis | MNDR-E-MI-47117 |
| MNDR | hsa-miR-381-3p | Breast cancer her3+ negative | MNDR-E-MI-47118 |
| MNDR | hsa-miR-381-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-47119 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ANO1 | Homo sapiens | RR00082904 |
TOP